Medical Research News

RSS

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

A recent study published in the preprint server bioRxiv in October 2020 describes a reliable animal model to demonstrate the powerful capacity of human neutralizing mAbs directed against SARS-CoV-2 to prevent viral binding the host cell receptor and thus block infection. This indicates the lifesaving value of mAbs in severe COVID-19.

29 Oct 2020

SMART researchers develop novel microcarrier for large-scale cell production

Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have developed a novel microcarrier for large-scale cell production and expansion that offers higher yield and cost-effectiveness compared to traditional methods, and reduces steps required in the cell retrieval process.

29 Oct 2020

Model includes spatial heterogeneity to analyze airborne disease spread

Researchers from the University of Copenhagen have included parameters that consider a spatially heterogeneous population for transmission in a new model for airborne disease transmission. This allows for estimating superspreaders and appropriate mitigation strategies.

29 Oct 2020

New mouth spray could help treat patients with rare genetic skin condition

A new spray for treating severely painful blisters, mouth ulceration and oral scarring in patients with a rare genetic skin condition is being developed by researchers at the University of Birmingham.

29 Oct 2020

COVID-19 patients at risk of fatal co-infection during ICU stays

Researchers in the UK have conducted a study showing that a high proportion of patients admitted to intensive care units (ICU) with coronavirus disease 2019 (COVID-19) acquire a secondary bacterial co-infection during their hospital stay.

29 Oct 2020

New machine learning-based approach helps detect atrial fibrillation drivers

Researchers from Skoltech and their US colleagues have designed a new machine learning-based approach for detecting atrial fibrillation drivers, small patches of the heart muscle that are hypothesized to cause this most common type of cardiac arrhythmia.

29 Oct 2020

App-based surveillance system enables early detection of COVID-19 hotspots

Researchers in the UK, United States, and Sweden have used large-scale self-reported app data to estimate coronavirus disease 2019 (COVID-19) incidence, prevalence, and effective reproductive number in England.

29 Oct 2020

More intensive, less frequent drug regimen could cure Chagas disease

Researchers in the University of Georgia's Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently available therapeutics could cure the infection that causes Chagas disease, a potentially life-threatening illness affecting up to 300,000 people in the United States.

29 Oct 2020

People with multiple depressive symptoms have higher stroke risk

People with multiple depressive symptoms have an increased risk for stroke, according to findings recently published in Neurology: Clinical Practice.

29 Oct 2020

Researchers identify a novel SARS-CoV-2 variant that spread widely across Europe in summer 2020

Researchers from Basel and Spain have identified a novel SARS-CoV-2 variant that has spread widely across Europe in recent months, according to an un-peer-reviewed preprint released this week.

29 Oct 2020

Study sheds light on the biological base of symptoms in autoimmune psychosis

Anti-NMDAR encephalitis is an autoimmune brain illness that is often mistaken by a psychiatric disorder since it causes psychoses and other behaviour alterations. Despite having these similarities, the illness does not respond to common antipsychotic treatments.

29 Oct 2020

Study suggests a role for the hypothalamus in genetic susceptibility to IBD

Using sophisticated 3D genomic mapping and integrating with public data resulting from genome-wide association studies, researchers at Children's Hospital of Philadelphia have found significant genetic correlations between inflammatory bowel disease and stress and depression.

29 Oct 2020

Study finds low risk of adverse events from cardiac MRI contrast agents

Contrast agents used to improve views of the heart on MRI carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large study from Europe published in Radiology: Cardiothoracic Imaging.

29 Oct 2020

Intercellular communication pathway drives motivation to seek cocaine

In the October 28, 2020 issue of the Journal of Neuroscience, researchers from the Medical University of South Carolina and the National Institutes of Health describe how reminders of drug use can change specific brain cells responsible for motivation, increasing the desire to seek drugs.

29 Oct 2020

DETECT study: Wearable fitness devices can improve public health efforts to control COVID-19

Examining data from the first six weeks of their landmark DETECT study, a team of scientists from the Scripps Research Translational Institute sees encouraging signs that wearable fitness devices can improve public health efforts to control COVID-19.

29 Oct 2020

Study examines COVID-19-related tweets to uncover public opinions, sentiments and trends

Twitter users initially didn't feel positive about the state of the economy, prevention, treatment and recovery concerning COVID-19.

29 Oct 2020

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Liver cancer from too much fat accumulation in the liver has been increasing in many countries including Japan.

29 Oct 2020

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

By exploiting type 1 interferon's ability to foster an antagonistic cellular environment for viral replication, a research group from France pinpointed DEAD-box RNA helicase DDX42 as an intrinsic inhibitor of HIV, but also other pathogenic viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Chikungunya virus.

29 Oct 2020

Remdesivir received FDA approval for treating COVID-19 patients: Benefits still not proven

The United States has become the epicenter of the world in the ever increasing pandemic of COVID-19. While public health prevention strategies of social distancing, crowd avoidance, masking and frequent hand washing are of proven benefit, effective drug therapies for treatment are sparse.

29 Oct 2020

Protein tenascin-C plays a role in glaucoma by regulating inflammatory processes

Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.

29 Oct 2020

Medical Research News

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

SMART researchers develop novel microcarrier for large-scale cell production

Model includes spatial heterogeneity to analyze airborne disease spread

New mouth spray could help treat patients with rare genetic skin condition

COVID-19 patients at risk of fatal co-infection during ICU stays

New machine learning-based approach helps detect atrial fibrillation drivers

App-based surveillance system enables early detection of COVID-19 hotspots

More intensive, less frequent drug regimen could cure Chagas disease

People with multiple depressive symptoms have higher stroke risk

Researchers identify a novel SARS-CoV-2 variant that spread widely across Europe in summer 2020

Study sheds light on the biological base of symptoms in autoimmune psychosis

Study suggests a role for the hypothalamus in genetic susceptibility to IBD

Study finds low risk of adverse events from cardiac MRI contrast agents

Intercellular communication pathway drives motivation to seek cocaine

DETECT study: Wearable fitness devices can improve public health efforts to control COVID-19

Study examines COVID-19-related tweets to uncover public opinions, sentiments and trends

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Remdesivir received FDA approval for treating COVID-19 patients: Benefits still not proven

Protein tenascin-C plays a role in glaucoma by regulating inflammatory processes

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News